Literature DB >> 1495897

Nebulization of liposomes. III. The effects of operating conditions and local environment.

R W Niven1, T M Carvajal, H Schreier.   

Abstract

Multilamellar liposomes (MLV) of saturated phosphatidylcholine and dipalmitoyl phosphatidylglycerol (DPPG) (9:1 mole ratio) containing 5,6-carboxyfluorescein (CF) were prepared and extruded through 1.0-micron polycarbonate membranes. Diluted aqueous dispersions were aerosolized for a total of 80 min using a Collison nebulizer under a variety of conditions. The effects of air pressure, temperature, buffer osmotic strength, and pH on nebulized liposome dispersions were studied. Changes in air pressure produced large changes in the percentage release of CF and ranged from 1.3% (4 psig) to 88.2% (50 psig) after 80 min of nebulization. The temperature of the nebulizer dispersions dropped during experiments. The extent of the temperature drop varied according to the air pressure used and ranged from 5 degrees C (4 psig) to 11 degrees C (greater than or equal to 30 psig). The temperature of dispersions caused no increase in CF release until the gel-to-liquid crystalline transition temperature was exceeded (54.6 degrees C), whereupon a 20% increase in leakage was observed after 80 min of nebulization. Aerosol mass output was relatively unaffected by the starting temperature of experiments when conducted within the ambient temperature range. Leakage from the liposomes was increased in hypotonic solution but decreased in hypertonic solutions. At a buffer pH of 2.85 the percentage leakage of CF was increased approximately 18% compared to that at pH 7.2 and pH 10.75. Results show that the stability of liposomes composed of saturated phosphatidylcholine and DPPG (9:1 mole ratio) is affected by the operating and environmental conditions under which aerosolization takes place, with air pressure having the greatest effect.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1495897     DOI: 10.1023/a:1015844430695

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  4 in total

1.  Nebulization of liposomes. II. The effects of size and modeling of solute release profiles.

Authors:  R W Niven; M Speer; H Schreier
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

2.  Room temperature influences output from the Wright jet nebulizer.

Authors:  J Kongerud; V Søyseth; B Johansen
Journal:  Eur Respir J       Date:  1989-07       Impact factor: 16.671

3.  The osmotic response of large unilamellar vesicles studied by quasielastic light scattering.

Authors:  E Hantz; A Cao; J Escaig; E Taillandier
Journal:  Biochim Biophys Acta       Date:  1986-11-17

4.  Nebulization of liposomes. I. Effects of lipid composition.

Authors:  R W Niven; H Schreier
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

  4 in total
  7 in total

Review 1.  Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Authors:  Sally-Ann Cryan
Journal:  AAPS J       Date:  2005-03-24       Impact factor: 4.009

2.  Two disaccharides and trimethylamine N-oxide affect Abeta aggregation differently, but all attenuate oligomer-induced membrane permeability.

Authors:  Wei Qi; Aming Zhang; Theresa A Good; Erik J Fernandez
Journal:  Biochemistry       Date:  2009-09-22       Impact factor: 3.162

3.  A dry powder formulation of liposome-encapsulated recombinant secretory leukocyte protease inhibitor (rSLPI) for inhalation: preparation and characterisation.

Authors:  Aileen Gibbons; Noel G McElvaney; Sally-Ann Cryan
Journal:  AAPS PharmSciTech       Date:  2010-09-15       Impact factor: 3.246

4.  Effect of cholesterol on the properties of spray-dried lysozyme-loaded liposomal powders.

Authors:  Dusadee Charnvanich; Nontima Vardhanabhuti; Poj Kulvanich
Journal:  AAPS PharmSciTech       Date:  2010-05-13       Impact factor: 3.246

5.  Liposomal dry powders as aerosols for pulmonary delivery of proteins.

Authors:  Dongmei Lu; Anthony J Hickey
Journal:  AAPS PharmSciTech       Date:  2005-12-21       Impact factor: 3.246

6.  Initial characterization of micafungin pulmonary delivery via two different nebulizers and multivariate data analysis of aerosol mass distribution profiles.

Authors:  Shuai Shi; Elizabeth S Dodds Ashley; Barbara D Alexander; Anthony J Hickey
Journal:  AAPS PharmSciTech       Date:  2009-02-03       Impact factor: 3.246

Review 7.  Inhaled chemotherapy in lung cancer: future concept of nanomedicine.

Authors:  Paul Zarogoulidis; Ekaterini Chatzaki; Konstantinos Porpodis; Kalliopi Domvri; Wolfgang Hohenforst-Schmidt; Eugene P Goldberg; Nikos Karamanos; Konstantinos Zarogoulidis
Journal:  Int J Nanomedicine       Date:  2012-03-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.